Anchyra Partners
BMY icon

Anchyra Partners’s Bristol-Myers Squibb BMY Stock Holding History

Anchyra Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$431K Buy
6,910
+285
+4% +$18K 0.09% 202
2026
Q2 		$382K Sell
6,625
-304
-4% -$17.5K 0.09% 198
2026
Q1 		$420K Buy
6,929
+471
+7% +$27.5K 0.13% 159
2025
Q4 		$348K Buy
+6,458
New +$311K 0.11% 177

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Anchyra Partners's BMY Position: Q3 2026 in Review

Anchyra Partners increased its Bristol-Myers Squibb (BMY) stake by 4.3% in Q3 2026, buying an estimated $18K and bringing the position to 6,910 shares worth $431K. The position accounts for 0.09% of the portfolio, ranked #202.

Anchyra Partners first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Anchyra Partners held 6,910 shares of Bristol-Myers Squibb worth $431K as of Q3 2026.
  • Anchyra Partners bought 285 Bristol-Myers Squibb shares in Q3 2026, an estimated $18K.
  • Bristol-Myers Squibb made up 0.09% of Anchyra Partners's portfolio in Q3 2026, its #202 holding.
  • Anchyra Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.